ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing November 20, 4:00 p.m. ET:

Nationwide Survey of Patients' Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences (JOP: Original Contribution)
Reshma Jagsi, et al.
Request this article

Publishing November 18, 4:00 p.m. ET:

Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions (JCO PO: Original Report)
Daniel Stover, et al.
Request this article

DNA Methylation Profiling Reveals Prognostically Significant Groups in Pediatric Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry (JCO PO: Original Report)
Michael Clay, et al.
Request this article

Publishing November 15, 4:00 p.m. ET:

Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil. A Subanalysis of the AMAZONA III Study (GBECAM 0115) (JGO: Original Report)
Marie Franzoi, et al.
Request this article

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials (JCO PO:Original Report)
Nancy Lin, et al.
Request this article

Publishing November 14, 4:00 p.m. ET:

Factors During a Child's Illness Are Associated With Levels of Prolonged Grief Symptoms in Bereaved Mothers and Fathers (JCO: Original Report)
Lilian Pohlkamp, et al.
Request this article

Publishing November 13, 4:00 p.m. ET:

Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features (JCO: Original Report)
Bradley McGregor, et al.
Request this article

Pattern of Presentation of Patients With Breast Cancer in Iraq in 2018: A Cross-Sectional Study (JGO: Original Report)
Mohammed Mutar, et al.
Request this article

Publishing November 12, 4:00 p.m. ET:

Long-Term Mental Health Outcomes in Mothers and Siblings of Children With Cancer: A Population-Based, Matched Cohort Study (JCO: Original Report)
Sumit Gupta, et al.
Request this article

Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non-Small-Cell Lung Cancer (JCO PO: Original Report)
Mark Awad, et al.
Request this article

Publishing November 08, 4:00 p.m. ET:

Dermatology-Driven Quality Improvement Interventions to Decrease Diagnostic Delays for Kaposi Sarcoma in Botswana (JGO: Original Report)
Victoria Williams, et al.
Request this article

Public Awareness and Perceptions of Radiotherapy and Their Influence on the Use of Radiotherapy in Dar es Salaam, Tanzania (JGO: Original Report)
Geofrey Soko, et al.
Request this article

Publishing November 07, 4:00 p.m. ET:

Parent's, Health Care Professionals', and Scientists' Experiences of a Precision Medicine Pilot Trial for Patients With High-Risk Childhood Cancer: A Qualitative Study (JCO PO: Original Report)
Janine Vetsch, et al. 
Request this article

Publishing November 06, 4:00 p.m. ET:

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (JCO: Original Report)
Laurie Sehn, et al. 
Request this article

Negotiating Lay and Clinical Issues: Implementing a Lay Navigation Program in Cancer Care (JOP: Original Contribution)
Marcy Winget, et al.
Request this article

Publishing November 05, 4:00 p.m. ET:

Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer (JCO: Original Report)
Daniel Danila, et al. 
Request this article

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.